140 related articles for article (PubMed ID: 7316505)
1. Immunological and biophysical alteration of hepatitis B virus antigens by sodium hypochlorite disinfection.
Sehulster LM; Hollinger FB; Dreesman GR; Melnick JL
Appl Environ Microbiol; 1981 Nov; 42(5):762-7. PubMed ID: 7316505
[TBL] [Abstract][Full Text] [Related]
2. Chemical disinfection of duck hepatitis B virus: a model for inactivation of infectivity of hepatitis B virus.
Tsiquaye KN; Barnard J
J Antimicrob Chemother; 1993 Aug; 32(2):313-23. PubMed ID: 8226434
[TBL] [Abstract][Full Text] [Related]
3. Nude mice bearing human primary hepatocellular carcinoma that produces hepatitis B surface, core, and e antigens, as well as deoxyribonucleic acid polymerase.
Matsui T; Takano M; Miyamoto K; Itoh Y; Yoshizawa H; Koike M; Mochizuki T; Tanaka E; Okamoto H; Imai M
Gastroenterology; 1986 Jan; 90(1):135-42. PubMed ID: 3509999
[TBL] [Abstract][Full Text] [Related]
4. Effect of alkaline glutaraldehyde on hepatitis B virus antigens.
Adler-Storthz K; Sehulster LM; Dreesman GR; Hollinger FB; Melnick JL
Eur J Clin Microbiol; 1983 Aug; 2(4):316-20. PubMed ID: 6414809
[TBL] [Abstract][Full Text] [Related]
5. Effects of amphotericin B on hepatitis B virus.
Kessler HA; Dixon J; Howard CR; Tsiquaye K; Zuckerman AJ
Antimicrob Agents Chemother; 1981 Dec; 20(6):826-33. PubMed ID: 7325646
[TBL] [Abstract][Full Text] [Related]
6. Dane particles and associated DNA-polymerase activity in saliva of chronic hepatitis B carriers.
Macaya G; Visoná KA; Villarejos VM
J Med Virol; 1979; 4(4):291-301. PubMed ID: 541682
[TBL] [Abstract][Full Text] [Related]
7. Demonstration of a firm association between hepatitis B surface antigen proteins bearing polymerized human albumin binding sites and core-specific determinants in serum hepatitis B viral particles.
Petit MA; Capel F; Pillot J
Mol Immunol; 1985 Nov; 22(11):1279-87. PubMed ID: 2417111
[TBL] [Abstract][Full Text] [Related]
8. [Construction and characterization of hepatitis B surface antigen "a" epitope virus-like particles].
Chen SY; Guo MZ; Qiu F; Fei YL; Yi Y; Guo Y; Jia ZY; Yu T; Bi SL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2010 Feb; 24(1):30-2. PubMed ID: 20848844
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis B core particles with endogenous DNA polymerase activity from chimpanzee liver.
Onda H; Matsuda S; Oka Y
Intervirology; 1978; 10(4):254-64. PubMed ID: 681146
[TBL] [Abstract][Full Text] [Related]
10. Inactivation of DNA-polymerase associated with hepatitis B virus.
Nath N; Fang CT; Dodd RY
J Med Virol; 1982; 10(2):131-40. PubMed ID: 7142978
[TBL] [Abstract][Full Text] [Related]
11. Mutated epitopes of hepatitis B surface antigen fused to the core antigen of the virus induce antibodies that react with the native surface antigen.
Shiau AL; Murray K
J Med Virol; 1997 Mar; 51(3):159-66. PubMed ID: 9139078
[TBL] [Abstract][Full Text] [Related]
12. Hepatitis B virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen.
Gutiérrez C; León G; Loureiro CL; Uzcátegui N; Liprandi F; Pujol FH
Clin Diagn Lab Immunol; 1999 Sep; 6(5):768-70. PubMed ID: 10473534
[TBL] [Abstract][Full Text] [Related]
13. Partial delipidation improves the T-cell antigenicity of hepatitis B virus surface antigen.
Desombere I; Willems A; Gijbels Y; Leroux-Roels G
J Virol; 2006 Apr; 80(7):3506-14. PubMed ID: 16537618
[TBL] [Abstract][Full Text] [Related]
14. [Destroying of antigenicity and influencing the immunochemical reactivity of hepatitis B virus antigens (HBsAg, HBcAg and HBeAg) through disinfectants--a proposed method for testing (author's transl)].
Frösner G; Jentsch G; Uthemann H
Zentralbl Bakteriol Mikrobiol Hyg B; 1982 Apr; 176(1):1-14. PubMed ID: 6180573
[TBL] [Abstract][Full Text] [Related]
15. A vaccine prepared from the 22 nm particles of surface hepatitis B antigen (HBsAg).
Karelin VP; Babaeva EE; Gubenko EF; Kaulen DK; Zhdanov VM
J Med Virol; 1980; 5(4):331-41. PubMed ID: 7229622
[TBL] [Abstract][Full Text] [Related]
16. Expression of hepatitis B virus-specific markers in asymptomatic hepatitis B surface antigen carriers.
Arnold GH; Shih JW; Kaplan PM; Purcell RH; Gerin JL; Bueschenfelde KH
Infect Immun; 1977 Sep; 17(3):550-4. PubMed ID: 71267
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus markers in anti-HBc only positive individuals.
Weber B; Melchior W; Gehrke R; Doerr HW; Berger A; Rabenau H
J Med Virol; 2001 Jul; 64(3):312-9. PubMed ID: 11424120
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B virus DNA in unusual serological profiles of hepatitis B surface antigen-positive sera.
Chongsrisawat V; Thawornsuk N; Theamboonlers A; Louisirirotchanakul S; Poovorawan Y
Viral Immunol; 2006; 19(4):623-9. PubMed ID: 17201657
[TBL] [Abstract][Full Text] [Related]
19. Hepatitis B virus reactivation and efficacy of prophylaxis with lamivudine in patients undergoing allogeneic stem cell transplantation.
Giaccone L; Festuccia M; Marengo A; Resta I; Sorasio R; Pittaluga F; Fiore F; Boccadoro M; Rizzetto M; Bruno B; Marzano A
Biol Blood Marrow Transplant; 2010 Jun; 16(6):809-17. PubMed ID: 20060484
[TBL] [Abstract][Full Text] [Related]
20. Correlation of improved hepatitis B surface antigen detection limits with hepatitis B virus DNA nucleic acid test yield in blood donations.
Martin LA; Stramer SL; Kuhns MC; Schlauder GG
Transfusion; 2012 Oct; 52(10):2201-8. PubMed ID: 22321072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
